Official Journal of the Crohn's and Colitis Foundation of America, Inc.

ATTENTION CCFA MEMBERS. Access to IBD on Wiley InterScience requires an easy registration. If you did not receive instructions with your first 2007 issues of IBD, or require assistance, please contact Lucy Woo, Membership Coordinator, lwoo@wiley.com.

Benefits of Publishing in IBD®.
Inflammatory Bowel Diseases® provides authors a unique forum to—
• Reach a Targeted Audience of Dedicated Professionals. IBD® reaches digestive disease specialists worldwide and is the official journal of The Crohn's and Colitis Foundation of America, Inc. , ensuring that your work, once accepted for publication, will receive optimal exposure to your North American and international colleagues.
• Access a State-of-the-Art Submission System. IBD® offers online manuscript submission and peer-review via Manuscript CentralTM ( http://mc.manuscriptcentral.com/ibd . ), a user-friendly system making manuscript submission and tracking quick, easy, and safe.
• Secure Rapid Online Publication through EarlyView . Your article will be posted online as soon as it is ready, before the release of the compiled print issue.
• Attain High Visibility. IBD® is now available online through Wiley Interscience ., Wiley’s Internet publishing platform Wiley InterScience has more than 60 million user sessions per year.
• Enhance Your Professional Standing By Being Part of a Tradition. Once accepted for publication, your name will join the list of world-renowned authors who have been published in IBD®. During its 12-year history, IBD® has published the works of major figures in the field, including many groundbreaking articles that have changed the standards of patient care.